Post-COVID paediatric dysautonomia arises from complex brain-heart-vascular network dysfunction, with tachycardia as a compensatory response rather than primary cardiac abnormality
The paper argues that post-COVID dysautonomia in children is primarily a disorder of central autonomic network dysfunction and neurovascular dysregulation, not a primary cardiac condition. Tachycardia is described as a compensatory physiological response to impaired venous return, endothelial injury, hypovolemia, and altered cerebral perfusion.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Post-COVID paediatric dysautonomia arises from complex brain-heart-vascular network dysfunction, with tachycardia as a compensatory response rather than primary cardiac abnormality The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Post-COVID paediatric dysautonomia arises from complex brain-heart-vascular network dysfunction, with tachycardia as a compensatory response rather than primary cardiac abnormality
This conclusion is most relevant to: Children and adolescents with post-COVID dysautonomia.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim? (Cardiology in the young, 2026) —
How It Works
The proposed biological pathway:
- ▸Central autonomic network dysfunction
- ▸Neurovascular dysregulation and impaired venous return
- ▸Endothelial injury and hypovolemia
- ▸Altered cerebral perfusion
- ▸Compensatory tachycardia as physiological response
Who Might Benefit
Evidence fit by population:
- ▸Children and adolescents with post-COVID dysautonomia
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Reported prevalence varies widely due to evolving definitions and heterogeneous referral patterns
- ▸Important gaps remain in disease definitions, mechanistic understanding, and evidence-based treatment
Frequently Asked Questions
Is post-COVID dysautonomia primarily a heart problem in children?▼
No, the paper argues it is primarily a brain-heart-vascular network disorder, with tachycardia being a compensatory response rather than a primary cardiac abnormality.
What are the common symptoms of paediatric post-COVID dysautonomia?▼
Common symptoms include dizziness, palpitations, exercise intolerance, fatigue, syncope, cognitive dysfunction, gastrointestinal symptoms, sleep disturbances, and post-exertional symptom exacerbation.
How is paediatric dysautonomia managed?▼
Management follows a stepwise, mechanism-guided approach including patient education, trigger avoidance, hydration and salt optimisation, lower-body compression, individualised exercise rehabilitation, pacing strategies, school accommodations, and phenotype-directed pharmacotherapy.
What clinical phenotypes are associated with post-COVID dysautonomia?▼
Clinical phenotypes include postural orthostatic tachycardia syndrome, neurocardiogenic syncope, orthostatic hypotension, inappropriate sinus tachycardia, and undifferentiated orthostatic intolerance.
References
- 1.Das B, Moodley M. “Post-COVID paediatric dysautonomia: never the heart, always the brain-myth or maxim?.” Cardiology in the young, 2026. PMID: 42403377 DOI: 10.1017/S1047951126113900